183 related articles for article (PubMed ID: 11833205)
1. Surveillance and prevention of hepatitis C in Australian prisons.
Dolan K
Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):68-9. PubMed ID: 11833205
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.
Gates JA; Post JJ; Kaldor JM; Pan Y; Haber PS; Lloyd AR; Dolan KA;
J Urban Health; 2004 Sep; 81(3):448-52. PubMed ID: 15273267
[TBL] [Abstract][Full Text] [Related]
3. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
[TBL] [Abstract][Full Text] [Related]
5. Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh.
Gorar ZA; Zulfikar I
J Pak Med Assoc; 2010 Jun; 60(6):476-9. PubMed ID: 20527648
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
8. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
9. A framework for management of hepatitis C in prisons.
Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
[TBL] [Abstract][Full Text] [Related]
11. Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T
J Viral Hepat; 2017 Feb; 24(2):111-116. PubMed ID: 27778436
[TBL] [Abstract][Full Text] [Related]
12. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.
Schulte B; Stöver H; Thane K; Schreiter C; Gansefort D; Reimer J
Int J Prison Health; 2009; 5(1):39-44. PubMed ID: 25758928
[TBL] [Abstract][Full Text] [Related]
13. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy.
Semaille C; Le Strat Y; Chiron E; Chemlal K; Valantin MA; Serre P; Caté L; Barbier C; Jauffret-Roustide M;
Euro Surveill; 2013 Jul; 18(28):. PubMed ID: 23870097
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C in Australian prisons: a national needs assessment.
Mina MM; Herawati L; Butler T; Lloyd A
Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.
Solomon L; Flynn C; Muck K; Vertefeuille J
J Urban Health; 2004 Mar; 81(1):25-37. PubMed ID: 15047781
[TBL] [Abstract][Full Text] [Related]
19. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F
Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]